RT Journal Article
SR Electronic
T1 Practical challenges to the clinical implementation of saliva for SARS-CoV-2 detection
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.27.20170589
DO 10.1101/2020.08.27.20170589
A1 Matic, Nancy
A1 Stefanovic, Aleksandra
A1 Leung, Victor
A1 Lawson, Tanya
A1 Ritchie, Gordon
A1 Li, Lynne
A1 Champagne, Sylvie
A1 Romney, Marc G.
A1 Lowe, Christopher F.
YR 2020
UL http://medrxiv.org/content/early/2020/09/01/2020.08.27.20170589.abstract
AB Due to global shortages of flocked nasopharyngeal swabs and appropriate viral transport media during the COVID-19 pandemic, alternate diagnostic specimens for SARS-CoV-2 detection are sought. The accuracy and feasibility of saliva samples collected and transported without specialized collection devices or media were evaluated. Saliva demonstrated good concordance with paired nasopharyngeal swabs for SARS-CoV-2 detection in 67/74 cases (90.5%), though barriers to saliva collection were observed in long-term care residents and outbreak settings. SARS-CoV-2 RNA was stable in human saliva at room temperature for up to 48 hours after initial specimen collection, informing appropriate transport time and conditions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study has been reviewed and approved by the Providence Health Care Research Ethics Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis article is a focused, brief report with all relevant data included in the manuscript.